Bio Port Korea Inc. (KOSDAQ:188040)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,830.00
-300.00 (-3.29%)
At close: Dec 5, 2025

Bio Port Korea Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023
Period Ending
Sep '25 Dec '24 Dec '23
Revenue
73,87973,34668,699
Revenue Growth (YoY)
-0.32%6.77%-
Cost of Revenue
53,99952,41149,616
Gross Profit
19,88120,93619,083
Selling, General & Admin
15,04214,50713,179
Research & Development
619.43504.95457.61
Amortization of Goodwill & Intangibles
26.829.489.48
Other Operating Expenses
225.15163.69133.25
Operating Expenses
16,69315,69614,164
Operating Income
3,1885,2404,919
Interest Expense
-336.04-1,512-2,108
Interest & Investment Income
517.48517.44408.99
Currency Exchange Gain (Loss)
218.6544.78206.96
Other Non Operating Income (Expenses)
-2,6531,467182.24
EBT Excluding Unusual Items
934.416,2583,609
Gain (Loss) on Sale of Investments
-18.23-13.91
Gain (Loss) on Sale of Assets
-6.7-924.59-
Pretax Income
927.715,3523,595
Income Tax Expense
3.291,240225.62
Net Income
924.434,1123,369
Net Income to Common
924.434,1123,369
Net Income Growth
-72.87%22.04%-
Shares Outstanding (Basic)
433
Shares Outstanding (Diluted)
544
Shares Change (YoY)
32.37%1.04%-
EPS (Basic)
234.331465.531347.75
EPS (Diluted)
234.331438.991302.58
EPS Growth
-82.05%10.47%-
Free Cash Flow
1,7438,491-1,253
Free Cash Flow Per Share
369.382372.83-353.75
Gross Margin
26.91%28.54%27.78%
Operating Margin
4.32%7.14%7.16%
Profit Margin
1.25%5.61%4.91%
Free Cash Flow Margin
2.36%11.58%-1.82%
EBITDA
5,4617,1026,328
EBITDA Margin
7.39%9.68%9.21%
D&A For EBITDA
2,2731,8621,409
EBIT
3,1885,2404,919
EBIT Margin
4.32%7.14%7.16%
Effective Tax Rate
0.35%23.16%6.28%
Advertising Expenses
-966.01768.83
Source: S&P Capital IQ. Standard template. Financial Sources.